Mettler-Toledo EPS - Earnings per Share 2010-2024 | MTD

Mettler-Toledo earnings per share (EPS) for the twelve months ending September 30, 2024 was $37.10, a 5.31% decline year-over-year.

  • Mettler-Toledo EPS for the quarter ending September 30, 2024 was $9.96, a 8.14% increase year-over-year.
  • Mettler-Toledo 2023 annual EPS was $35.9, a 6.53% decline from 2022.
  • Mettler-Toledo 2022 annual EPS was $38.41, a 17.18% increase from 2021.
  • Mettler-Toledo 2021 annual EPS was $32.78, a 31.59% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Mettler-Toledo EPS - Earnings per Share 2010-2024 | MTD

  • Mettler-Toledo EPS for the quarter ending September 30, 2024 was $9.96, a 8.14% increase year-over-year.
  • Mettler-Toledo 2023 annual EPS was $35.9, a 6.53% decline from 2022.
  • Mettler-Toledo 2022 annual EPS was $38.41, a 17.18% increase from 2021.
  • Mettler-Toledo 2021 annual EPS was $32.78, a 31.59% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$228.6B
Intuitive Surgical (ISRG)$203.7B
Alcon (ALC)$44.9B
Edwards Lifesciences (EW)$42.7B
IQVIA Holdings (IQV)$36.5B
IDEXX Laboratories (IDXX)$34.6B
DexCom (DXCM)$33.9B
Waters (WAT)$24.7B
STERIS (STE)$21.8B
SONOVA HOLDING (SONVY)$20.8B
Hologic (HOLX)$16.3B
Fresenius Medical Care AG KGaA (FMS)$14.6B
Globus Medical (GMED)$12.6B
Sysmex ADR (SSMXY)$12B
Penumbra (PEN)$10.2B
Masimo (MASI)$9.3B
Glaukos (GKOS)$8.6B
Teleflex (TFX)$8.4B
Integer Holdings (ITGR)$4.8B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$3.8B
Veracyte (VCYT)$3.5B
LivaNova (LIVN)$2.7B
Nihon Kohden (NHNKY)$2.6B
Tandem Diabetes Care (TNDM)$2.4B
TransMedics (TMDX)$2.3B
Elekta AB (EKTAY)$2.3B
Integra LifeSciences Holdings (IART)$2B
Alphatec Holdings (ATEC)$1.7B
RxSight (RXST)$1.4B